athenahealth Reports Third Quarter Fiscal Year 2017 Results

Go back to athenahealth Reports Third Quarter Fiscal Year 2017 Results

athenahealth (ATHN) PT Lowered to $155 at Baird Following Conference Call

October 23, 2017 8:52 AM EDT

Baird lowered its price target on athenahealth (NASDAQ: ATHN) to $155.00 (from $170.00) while maintaining a Outperform rating following conference call. Commentary from the call was mostly positive. Management emphasized non-GAAP EBIT margins for 2018 would be at least 15% for the full year, which implies run-rate... More

Athenahealth (ATHN) Tops Q3 EPS by 6c, to Cut Workforce 9%

October 19, 2017 4:03 PM EDT

Athenahealth (NASDAQ: ATHN) reported Q3 EPS of $0.56, $0.06 better than the analyst estimate of $0.50. Revenue for the quarter came in at $304.6 million versus the consensus estimate of $310.52 million.

Update on Strategic Initiatives to Drive Increased Levels of Profitable Growth and Enhance Shareholder Value

As previously announced on August 1, 2017, the Board of Directors and management team have been conducting a strategic review of our operational and financial strategy, leadership and governance. As a result of this review, today we are announcing an increase to our previously identified cost savings target. On October 13, 2017, the Board approved a... More